Correlation Between Cipher Pharmaceuticals and Cannabis Strategic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Cannabis Strategic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Cannabis Strategic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Cannabis Strategic Ventures, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Cannabis Strategic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Cannabis Strategic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Cannabis Strategic.

Diversification Opportunities for Cipher Pharmaceuticals and Cannabis Strategic

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Cipher and Cannabis is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Cannabis Strategic Ventures in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Strategic and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Cannabis Strategic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Strategic has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Cannabis Strategic go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Cannabis Strategic

Assuming the 90 days horizon Cipher Pharmaceuticals is expected to under-perform the Cannabis Strategic. But the otc stock apears to be less risky and, when comparing its historical volatility, Cipher Pharmaceuticals is 155.21 times less risky than Cannabis Strategic. The otc stock trades about -0.22 of its potential returns per unit of risk. The Cannabis Strategic Ventures is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  0.70  in Cannabis Strategic Ventures on August 26, 2024 and sell it today you would lose (0.69) from holding Cannabis Strategic Ventures or give up 98.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy5.45%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Cannabis Strategic Ventures

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Cannabis Strategic 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Strategic Ventures are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating technical and fundamental indicators, Cannabis Strategic unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cipher Pharmaceuticals and Cannabis Strategic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Cannabis Strategic

The main advantage of trading using opposite Cipher Pharmaceuticals and Cannabis Strategic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Cannabis Strategic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Strategic will offset losses from the drop in Cannabis Strategic's long position.
The idea behind Cipher Pharmaceuticals and Cannabis Strategic Ventures pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years